3B Blackbio Dx Past Earnings Performance
Past criteria checks 5/6
3B Blackbio Dx has been growing earnings at an average annual rate of 9.2%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been growing at an average rate of 8.4% per year. 3B Blackbio Dx's return on equity is 13.5%, and it has net margins of 40.2%.
Key information
9.2%
Earnings growth rate
8.1%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 8.4% |
| Return on equity | 13.5% |
| Net Margin | 40.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How 3B Blackbio Dx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 787 | 317 | 68 | 0 |
| 30 Sep 23 | 760 | 281 | 66 | 0 |
| 30 Jun 23 | 734 | 249 | 55 | 0 |
| 31 Mar 23 | 691 | 259 | 54 | 0 |
| 31 Dec 22 | 701 | 263 | 45 | 0 |
| 30 Sep 22 | 684 | 253 | 41 | 0 |
| 30 Jun 22 | 663 | 191 | 38 | 0 |
| 31 Mar 22 | 875 | 322 | 38 | 0 |
| 31 Dec 21 | 873 | 443 | 36 | 0 |
| 30 Sep 21 | 1,157 | 580 | 34 | 0 |
| 30 Jun 21 | 2,109 | 891 | 41 | 0 |
| 31 Mar 21 | 2,296 | 1,139 | 47 | 0 |
| 31 Dec 20 | 2,173 | 965 | 42 | 0 |
| 30 Sep 20 | 1,799 | 786 | 43 | 0 |
| 30 Jun 20 | 778 | 294 | 36 | 0 |
| 31 Mar 20 | 305 | 77 | 29 | 0 |
| 31 Dec 19 | 288 | 62 | 29 | 0 |
| 30 Sep 19 | 274 | 62 | 27 | 0 |
| 30 Jun 19 | 255 | 54 | 26 | 0 |
| 31 Mar 19 | 240 | 52 | 26 | 0 |
| 31 Dec 18 | 234 | 45 | 24 | 0 |
| 30 Sep 18 | 235 | 38 | 23 | 0 |
| 30 Jun 18 | 234 | 35 | 22 | 0 |
| 31 Mar 18 | 235 | 34 | 21 | 0 |
| 31 Dec 17 | 212 | 29 | 22 | 0 |
| 30 Sep 17 | 197 | 24 | 21 | 0 |
| 30 Jun 17 | 180 | 18 | 21 | 0 |
| 31 Mar 17 | 164 | 11 | 20 | 0 |
| 31 Dec 16 | 178 | 9 | 20 | 0 |
| 30 Sep 16 | 178 | 9 | 20 | 0 |
| 30 Jun 16 | 173 | 5 | 20 | 0 |
| 31 Mar 16 | 174 | 3 | 20 | 0 |
| 31 Dec 15 | 193 | 2 | 33 | 2 |
| 30 Sep 15 | 180 | 3 | 33 | 2 |
| 30 Jun 15 | 189 | 3 | 20 | 0 |
| 31 Mar 15 | 190 | 2 | 19 | 0 |
| 31 Dec 14 | 160 | 1 | 39 | 2 |
| 30 Sep 14 | 181 | 0 | 37 | 2 |
| 30 Jun 14 | 207 | 0 | 20 | 0 |
| 31 Mar 14 | 220 | 4 | 34 | 2 |
| 31 Dec 13 | 212 | 3 | 32 | 2 |
| 30 Sep 13 | 216 | 4 | 33 | 2 |
| 30 Jun 13 | 210 | 6 | 16 | 0 |
Quality Earnings: 532067 has high quality earnings.
Growing Profit Margin: 532067's current net profit margins (40.2%) are higher than last year (37.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 532067's earnings have grown by 9.2% per year over the past 5 years.
Accelerating Growth: 532067's earnings growth over the past year (20.4%) exceeds its 5-year average (9.2% per year).
Earnings vs Industry: 532067 earnings growth over the past year (20.4%) exceeded the Chemicals industry -6.1%.
Return on Equity
High ROE: 532067's Return on Equity (13.5%) is considered low.